Vyome Holdings HIND
NASDAQ HIND
$1.91 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vyome Holdings (HIND) Income from Non-Controlling Interests (2025 - 2026)

Updated

Vyome Holdings (HIND) recorded Income from Non-Controlling Interests of -$34,127 in Q2 2026.

Analysis

Vyome Holdings (HIND) Income from Non-Controlling Interests (2025 - 2026) Analysis & Trends

On a TTM basis, Vyome Holdings' Income from Non-Controlling Interests came in at -$272,444 as of Jun 30, 2026; for FY2025, it came in at -$215,706.

  • Quarterly Income from Non-Controlling Interests has ranged from -$161,489 in Q3 2025 to -$22,611 in Q1 2026 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -$22,611 (Q1 2026), -$54,217 (Q4 2025) and -$161,489 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -2.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -7.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 10.00 Mn
10 Vyome Holdings 13.41 Mn -12.70 Mn 11,658.00 -34,127.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -34,127.00
Mar 31, 2026 -22,611.00
Dec 31, 2025 -54,217.00
Sep 30, 2025 -161,489.00
API Access

Vyome Holdings Income from Non-Controlling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=HIND&period=max&api_key=YOUR_API_KEY